文献速递肝胆胰外科围术期管理与 ERAS

ALPPS风险调整与早期死亡率和并发症显著下降相关

Risk Adjustment in ALPPS Is Associated With a Dramatic Decrease in Early Mortality and Morbidity.
PubMed 文献 · Ann Surg · 2017-01-01

该纵向研究基于国际ALPPS注册中心16个中心437例患者,评估2009至2015年间风险调整与术后结局的关系。结果显示90天死亡率从最初的17%降至2015年的4%(P=0.002),主要跨期并发症从10%降至3%(P=0.011),死亡率的降低独立关联于患者选择的风险调整和一期手术采用更微创的技术。

要点

  • ALPPS的90天死亡率从17%降至4%,主要跨期并发症从10%降至3%。
  • 死亡率降低独立关联于患者选择的风险调整和一期手术更微创技术。
  • 所有中心均进行了患者选择的风险调整,80%的中心调整了ALPPS技术。

核心结论

  • ALPPS中患者选择和技术风险调整导致早期死亡率和主要术后并发症持续下降,已达到重大肝脏手术可接受的标准结局指标。

研究设计与样本

  • 纵向研究,纳入国际ALPPS注册中心中在≥3年内完成≥10例的16个中心共437例患者,研究期为2009至2015年。
  • 评估90天死亡率和主要跨期并发症(≥3b),计算每位患者一期和二期术前预测死亡风险,并向所有中心发放问卷探索中心特异性风险调整策略。

主要发现

  • 适应证从结直肠肝转移53%转变为77%,胆道肿瘤从24%反向趋势至9%。
  • 90天死亡率从最初17%降至2015年4%(P=0.002)。
  • 主要跨期并发症从10%降至3%(P=0.011)。
  • 90天死亡率降低独立关联于患者选择的风险调整(P<0.001;OR:1.62;95%CI:1.36-1.93)。
  • 90天死亡率降低独立关联于一期手术采用更微创技术(P=0.019;OR:0.39;95%CI:0.18-0.86)。

关键数值与推荐

  • 问卷显示所有中心均进行了患者选择的风险调整,多数(80%)中心调整了ALPPS技术。

临床怎么用

  • 在ALPPS实践中应进行患者选择的风险调整,并在一期手术中采用更微创的技术,以降低早期死亡率和主要并发症。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: To longitudinally assess whether risk adjustment in Associating Liver Partition and Portal Vein Ligation for Staged Hepatectomy (ALPPS) occurred over time and is associated with postoperative outcome. BACKGROUND: ALPPS is a novel 2-stage hepatectomy enabling resection of extensive hepatic tumors. ALPPS has been criticized for its high mortality, which is reported beyond accepted standards in liver surgery. Therefore, adjustments in patient selection and technique have been performed but have not yet been studied over time in relation to outcome. METHODS: ALPPS centers of the International ALPPS Registry having performed ≥10 cases over a period of ≥3 years were assessed for 90-day mortality and major interstage complications (≥3b) of the longitudinal study period from 2009 to 2015. The predicted prestage 1 and 2 mortality risks were calculated for each patient. In addition, questionnaires were sent to all centers exploring center-specific risk adjustment strategies. RESULTS: Among 437 patients from 16 centers, a shift in indications toward colorectal liver metastases from 53% to 77% and a reverse trend in biliary tumors from 24% to 9% were observed. Over time, 90-day mortality decreased from initially 17% to 4% in 2015 (P = 0.002). Similarly, major interstage complications decreased from 10% to 3% (P = 0.011). The reduction of 90-day mortality was independently associated with a risk adjustment in patient selection (P < 0.001; OR: 1.62; 95% CI: 1.36-1.93) and using less invasive techniques in stage-1 surgery (P = 0.019; OR: 0.39; 95% CI: 0.18-0.86). A survey indicated risk adjustment of patient selection in all centers and ALPPS technique in the majority (80%) of centers. CONCLUSIONS: Risk adjustment of patient selection and technique in ALPPS resulted in a continuous drop of early mortality and major postoperative morbidity, which has meanwhile reached standard outcome measures accepted for major liver surgery.

来源:Ann Surg,查看原文。版权归原作者所有。

引用

  1. Linecker M, Björnsson B, Stavrou GA, et al. Risk Adjustment in ALPPS Is Associated With a Dramatic Decrease in Early Mortality and Morbidity. Ann Surg. 2017. PMID: 28806301. doi:10.1097/SLA.0000000000002446

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。